2025. Metastatic Hormone-Sensitive Prostate Cancer: The Role of Docetaxel in Triple-Therapy Regimens. Voprosy onkologii. 71, 4 (Sep. 2025), OF-2167. DOI:https://doi.org/10.37469/0507-3758-2025-71-4-OF-2167.